Drug Hunter
New Drug Hunter content, featured events and job postings straight to your inbox. Trusted by >4,000 drug hunters worldwide, unsubscribe anytime.
Home > daridorexant
<< Back to November
dual orexin receptor GPCR antagonist
Ph. III efficacy for insomnia, oral 25-50 mg
from optimization of prior clinical candidate
ChemMedChem., Oct. 28, 2020
Idorsia Pharmaceuticals, Allschwil, CH
Idorsia clinical dual orexin receptor GPCR antagonist
Unlock this content with a Premium membership to read it now.